Literature DB >> 24917749

Percutaneous Nephrolithotomy in Autosomal Dominant Polycystic Kidney Disease: Is it Different from Percutaneous Nephrolithotomy in Normal Kidney?

Vishwajeet Singh1, Rahul Janak Sinha1, Dheeraj Kumar Gupta1.   

Abstract

OBJECTIVES: Nephrolithiasis has been reported in 20-28% of patients, of whom 50% are symptomatic for stone disease and 20% require definite urologic intervention. The management of nephrolithiasis includes oral alkali dissolution therapy, extracorporeal shock wave lithotripsy and surgical treatment. In such patients, percutaneous nephrolithotomy (PNL) as a method of stone treatment has been reported in few cases with limited experience. The aim of this study is to present our experience of PNL in autosomal dominant polycystic kidney disease (ADPKD) and assessing the outcome results.
MATERIAL AND METHODS: From 2002 to 2011, 22 patients (26 renal units) suffering from ADPKD with stone were managed by PNL. Demographic characteristics, operative parameters and postoperative complications were recorded and analysed. RESULT: The overall success rate of PNL was 82.1% and PNL with extracorporeal shock wave lithotripsy for clinically significant residual fragments was 92.85% respectively. The hematuria required blood transfusion (n = 9), postoperative fever due to cyst infection (n = 4) and paralytic ileus (n = 3) were recorded.
CONCLUSION: The PNL in ADPKD PNL is safe and effective but have more postoperative complications such as bleeding requiring transfusions, fever due to cyst infection and paralytic ileus.

Entities:  

Keywords:  Autosomal dominant polycystic kidney disease; Nephrolithiasis; Percutaneous nephrolithotomy

Year:  2013        PMID: 24917749      PMCID: PMC3783285          DOI: 10.1159/000343545

Source DB:  PubMed          Journal:  Curr Urol        ISSN: 1661-7649


  21 in total

1.  Extracorporeal shockwave lithotripsy for urinary calculi in autosomal dominant polycystic kidney disease.

Authors:  D Delakas; G Daskalopoulos; A Cranidis
Journal:  J Endourol       Date:  1997-06       Impact factor: 2.942

2.  Nephrolithiasis associated with autosomal dominant polycystic kidney disease: contemporary urological management.

Authors:  C S Ng; A Yost; S B Streem
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

3.  Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease.

Authors:  S A Grampsas; P S Chandhoke; J Fan; M A Glass; R Townsend; A M Johnson; P Gabow
Journal:  Am J Kidney Dis       Date:  2000-07       Impact factor: 8.860

4.  A prospective randomized study comparing percutaneous nephrolithotomy under combined spinal-epidural anesthesia with percutaneous nephrolithotomy under general anesthesia.

Authors:  Vishwajeet Singh; Rahul Janak Sinha; S N Sankhwar; Anita Malik
Journal:  Urol Int       Date:  2011-09-14       Impact factor: 2.089

5.  Percutaneous nephrolithotomy in polycystic kidney disease: is it safe and effective?

Authors:  Aneesh Srivastava; Rajesh Bansal; Alok Srivastava; Samit Chaturvedi; Priyadarshi Ranjan; M S Ansari; Abhishek Yadav; Rakesh Kapoor
Journal:  Int Urol Nephrol       Date:  2011-11-20       Impact factor: 2.370

Review 6.  Renal stone disease in autosomal dominant polycystic kidney disease.

Authors:  V E Torres; D M Wilson; R R Hattery; J W Segura
Journal:  Am J Kidney Dis       Date:  1993-10       Impact factor: 8.860

Review 7.  Intestinal obstruction in autosomal dominant polycystic kidney disease.

Authors:  Kaheita Kakinoki; Yatsugi Noda; Masayoshi Takaeda; Masahiro Kubo; Keiichi Mizuhashi; Ichirou Miyamoto; Tetsuya Nishida; Yasuhiro Takemori
Journal:  Intern Med       Date:  2002-06       Impact factor: 1.271

8.  The influence of renal manifestations to the progression of autosomal dominant polycystic kidney disease.

Authors:  A Idrizi; M Barbullushi; E Petrela; S Kodra; A Koroshi; N Thereska
Journal:  Hippokratia       Date:  2009-07       Impact factor: 0.471

9.  Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients.

Authors:  José L Nishiura; Rodrigo F C A Neves; Samara R M Eloi; Susan M L F Cintra; Sergio A Ajzen; Ita P Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

10.  Management of nephrolithiasis in autosomal dominant polycystic kidney disease - A single center experience.

Authors:  Ramen Baishya; Divya R Dhawan; Abraham Kurien; Arvind Ganpule; Ravindra B Sabnis; Mahesh R Desai
Journal:  Urol Ann       Date:  2012-01
View more
  3 in total

Review 1.  Efficacy and Safety of Surgical Kidney Stone Interventions in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review.

Authors:  Vinusha Kalatharan; Racquel Jandoc; Gary Grewal; Danielle M Nash; Blayne Welk; Sisira Sarma; York Pei; Amit X Garg
Journal:  Can J Kidney Health Dis       Date:  2020-07-22

2.  Fluoroscopy versus ultrasonography guided mini-percutaneous nephrolithotomy in patients with autosomal dominant polycystic kidney disease.

Authors:  Heyang Sun; Ze Zhang; Guanghao Huang; Shaw P Wan; Huade Chen; Bolin He; Jian Yuan; Yongda Liu
Journal:  Urolithiasis       Date:  2016-07-04       Impact factor: 3.436

3.  Percutaneous Nephrolithotomy under Ultrasound Guidance in Patients with Renal Calculi and Autosomal Dominant Polycystic Kidney Disease: A Report of 11 Cases.

Authors:  Xiao Wang; Xuecheng Yang; Xiulong Zhong; Zhenlin Wang; Senyao Xue; Weifeng Yu; Zhen Dong
Journal:  Adv Urol       Date:  2017-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.